Corium International, Inc. is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products. The Company�s marketed products are Clonidine Transdermal Delivery System (TDS), Fentanyl TDS and four Crest Advanced Seal Whitestrips products. It has developed two technology platforms, Corplex and MicroCor. It uses its Corplex technology to create advanced transdermal and transmucosal systems for small molecules that utilize less of the active ingredient. Its MicroCor technology is a biodegradable microstructure system under development that enables the painless delivery of biologics that otherwise must be delivered via injection. The advanced clinical-stage product in its pipeline is AG200-15, which is in Phase III development.